Nuwellis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Nuwellis, Inc. on March 14, 2023. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The registrant is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol NUWE.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding a corporate event rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces a scheduled management presentation.
Guidance, Outlook, and Management Commentary
Management announced a presentation at the Oppenheimer Annual Healthcare Conference held virtually on March 14, 2023, at 9:20 a.m. Eastern Time. The presentation slide deck is included as Exhibit 99.1. The filing explicitly states that the information furnished, including the presentation, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of the presentation deck (Exhibit 99.1) for any forward-looking statements or strategic updates not detailed in the 8-K text.
- Note that the presentation materials are furnished but not legally "filed" under Section 18 of the Exchange Act.
- Confirm the date and time of the Oppenheimer Annual Healthcare Conference presentation (March 14, 2023, 9:20 a.m. ET).